Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Three novel series of vanilloid VR1 antagonists presented by GSK

Nov. 2, 2004

Gruenenthal describes new NOS inhibitors with analgesic activity

Oct. 29, 2004

New GSK-3beta inhibitors and their use in Alzheimer's disease and other disorders

Oct. 29, 2004

New alpha2delta-selective calcium channel ligands discovered at Pfizer

Oct. 29, 2004

Encysive scientists design new urotensin II antagonists

Oct. 29, 2004

New antirotavirus agents prepared and tested at ViroPharma

Oct. 29, 2004

Guilford researchers present novel NAALADase inhibitors

Oct. 29, 2004

Novel antibacterial methionyl tRNA synthetase inhibitors claimed by Replidyne

Oct. 29, 2004

Vertex describes Na+ and/or Ca2+ channel blockers for pain and other uses

Oct. 28, 2004

New ALK5 inhibitors covered by Pfizer patent

Oct. 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...